Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Lipid panel

Measures total cholesterol, LDL cholesterol (LDL-C), HDL cholesterol (HDL-C) and triglycerides to assess cardiovascular risk. Whether treatment is needed depends on overall risk, taking in age, blood pressure, blood sugar, smoking and other factors.

Sample: Venous blood (serum)
Preparation: Usually no fasting needed. If your triglycerides come back high, your doctor may ask for a repeat test after fasting.

When it is worth testing

Common cut-offs

Borderline high LDL-C130–159 mg/dL (3.4–4.1 mmol/L)
High LDL-C≥ 160 mg/dL (≥ 4.1 mmol/L)
Borderline high triglycerides150–199 mg/dL (1.7–2.3 mmol/L)
High triglycerides≥ 200 mg/dL (≥ 2.3 mmol/L)
Low HDL-C< 40 mg/dL (< 1.0 mmol/L)

Related supplements

High-potency omega-3 (EPA/DHA, SPM precursors) Recheck while taking

When fish oil is used to help lower triglycerides, recheck the lipid panel after about 2 months to see the effect. The evidence for high-dose prescription-strength fish oil (4 g/day) cannot be applied directly to ordinary doses.

Pterostilbene Recheck while taking

A small trial found that pterostilbene taken alone (100–250 mg/day) raised LDL-C. People with cardiovascular risk should have their lipids rechecked about 2 months after starting it.

Immediate-release niacin (vitamin B3) Recheck while taking

When niacin is used under medical supervision to adjust blood lipids, recheck the lipid panel to see the effect.

Notes

References (4)
  1. Li 2023 · J Geriatr Cardiol · Guideline, review or authoritative source — 2023 China Guidelines for Lipid Management
  2. Skulas-Ray 2019 · Circulation · Guideline, review or authoritative source — Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
  3. Riche 2014 · Evid Based Complement Alternat Med · RCT · n=80 — Pterostilbene on metabolic parameters: a randomized, double-blind, and placebo-controlled trial
  4. Lupin Pharmaceuticals, Inc. 2023 · DailyMed, National Library of Medicine · Guideline, review or authoritative source — NIACIN tablet, extended release: prescribing information
Open in the interactive app ›